State WV
Clinical Trials in West Virginia
West Virginia is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in West Virginia and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 51 actively recruiting studies with West Virginia sites out of 51 registered in total. The busiest research areas in West Virginia are Hypertension, Multiple Myeloma, Migraine. Leading sponsors running trials in the state include West Virginia University, AbbVie, SWOG Cancer Research Network. By stage, West Virginia trials break down as Phase 1 (4), Phase 2 (11), Phase 3 (23), Phase 4 (1).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in West Virginia
Hypertension (2)Multiple Myeloma (2)Migraine (2)Diabetes Mellitus, Type 2 (2)Non-Small Cell Lung Cancer (NSCLC) (1)Circadian Rhythm Disorders (1)Advanced Or Metastatic Merkel Cell Carcinoma (1)Low Grade Astrocytoma (1)Low Grade Glioma (1)Metastatic Low Grade Astrocytoma (1)Metastatic Low Grade Glioma (1)WHO Grade 1 Glioma (1)
Frequently Asked Questions — Clinical Trials in West Virginia
How many clinical trials are currently recruiting in West Virginia?
ClinicalMetric currently tracks 51 actively recruiting clinical trials with at least one location in West Virginia. The total number of registered studies—including active but not currently enrolling trials—is 51. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in West Virginia?
West Virginia hosts clinical trials across a broad range of medical conditions, including Hypertension, Multiple Myeloma, Migraine, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout West Virginia serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in West Virginia?
To join a clinical trial in West Virginia, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in West Virginia maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in West Virginia
NCT06959524 N/A
Recruiting
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Co...
Condition
Coronary Arterial Disease (CAD)
Enrollment
1,616 pts
Location
United States, Australia, China
Sponsor
Boston Scientific Corporation
NCT06264180 Phase 3
Recruiting
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on A...
Condition
Advanced Melanoma
Enrollment
400 pts
Location
United States, France, Germany
Sponsor
Replimune, Inc.
NCT07481383 Phase 1
Recruiting
A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delive...
Condition
Pancreatic Adenocarcinoma Non-resectable
Enrollment
12 pts
Location
United States
Sponsor
Continuity Biosciences, LLC
NCT07216872 N/A
Recruiting
Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation...
Condition
Alcohol Use Disorder
Enrollment
186 pts
Location
United States, Israel, Sweden
Sponsor
Brainsway
NCT07443254 Phase 1, Phase 2
Recruiting
Prospective IR-led Sedation Feasibility
Condition
Anesthesia
Enrollment
40 pts
Location
United States
Sponsor
CAMC Health System
NCT07069400 N/A
Recruiting
An International Observational Study of Adults With Acute Infection
Condition
Infectious Disease
Enrollment
1,500 pts
Location
United States, Argentina, Australia
Sponsor
University of Minnesota
NCT07662109 Phase 3
Recruiting
A Phase III Study to Investigate the Efficacy and Safety of the Combination of E...
Condition
Type 2 Diabetes Mellitus
Enrollment
2,000 pts
Location
United States, Argentina, Brazil
Sponsor
AstraZeneca
NCT06958328 Phase 3
Recruiting
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Condition
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma
Enrollment
356 pts
Location
United States, Canada
Sponsor
NRG Oncology
NCT06246916 Phase 3
Recruiting
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Partic...
Condition
Melanoma
Enrollment
560 pts
Location
United States, Canada
Sponsor
Regeneron Pharmaceuticals
NCT07061964 Phase 2
Recruiting
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Rem...
Condition
Muscle Invasive Bladder Urothelial Carcinoma
Enrollment
111 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT07555938 Phase 3
Recruiting
Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of...
Condition
Multiple Myeloma
Enrollment
380 pts
Location
United States, Australia, Brazil
Sponsor
Hoffmann-La Roche
NCT07415954 Phase 2
Recruiting
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419...
Condition
Diabetes Mellitus, Type 2
Enrollment
270 pts
Location
United States, Croatia, Hungary
Sponsor
Novo Nordisk A/S
NCT07064473 Phase 3
Recruiting
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empag...
Condition
Diabetes Mellitus, Type 2
Enrollment
11,800 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
NCT05934487 N/A
Recruiting
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Condition
Heart Failure NYHA Class II
Enrollment
1,750 pts
Location
United States, Belgium, Ireland
Sponsor
Endotronix, Inc.
NCT06820164 Phase 1, Phase 2
Recruiting
Lipomas Treated With Subcutaneous Injections of Cooled or Warmed Sodium Chloride
Condition
Lipoma
Enrollment
20 pts
Location
United States
Sponsor
West Virginia University
NCT07190222 Phase 3
Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in ...
Condition
Chronic Obstructive Pulmonary Disease
Enrollment
942 pts
Location
United States, Argentina, Australia
Sponsor
Sanofi
NCT04293562 Phase 3
Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilterit...
Condition
Acute Myeloid Leukemia
Enrollment
1,186 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT06116682 Phase 2
Recruiting
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Co...
Condition
Lung Non-Small Cell Carcinoma
Enrollment
88 pts
Location
United States
Sponsor
SWOG Cancer Research Network
NCT04965675 Phase 3
Recruiting
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
Condition
Chronic Migraine in Children
Enrollment
285 pts
Location
United States, Argentina, Canada
Sponsor
H. Lundbeck A/S
NCT04748601 Phase 4
Recruiting
Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
Condition
Migraine Disorders
Enrollment
132 pts
Location
United States
Sponsor
Upsher-Smith Laboratories
NCT03339128 Phase 2
Recruiting
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bow...
Condition
Irritable Bowel Syndrome
Enrollment
95 pts
Location
United States, Bulgaria, Canada
Sponsor
AbbVie
NCT06631287 Phase 3
Recruiting
Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSi...
Condition
Long COVID
Enrollment
550 pts
Location
United States
Sponsor
Wes Ely
NCT07365241 Phase 3
Recruiting
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous...
Condition
Small Cell Lung Cancer
Enrollment
531 pts
Location
United States, Austria, Belgium
Sponsor
AbbVie
NCT07222579 Phase 2
Recruiting
Subcutaneous Blinatumomab for Treatment of Adult Patients With CD19-Positive Mix...
Condition
CD19 Positive
Enrollment
78 pts
Location
United States
Sponsor
West Virginia University
NCT05164172 Phase 3
Recruiting
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chroni...
Condition
Migraine
Enrollment
600 pts
Location
United States, Argentina, Canada
Sponsor
H. Lundbeck A/S
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology